Brief: Roivant Sciences Authorizes $500 Million Share Repurchase Program
25/06/2025 12:35
June 25 (Reuters) - Roivant Sciences Ltd ROIV.O: ROIVANT SCIENCES LTD - AUTHORIZES $500 MILLION SHARE REPURCHASE PROGRAM - SEC FILING Further company coverage: ROIV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roivant Sciences
See all newsU.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
Roivant rises as drug succeeds in two late-stage trials for eye disease
Immunovant falls after lupus drug setback
Brief: Roivant Announces Topline Results From Proof-Of-Concept Study Of Imvt-1402 In Cutaneous Lupus Erythematosus
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple